These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1248262

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Saralasin test, renal vein renin and unilateral kidney blood flow in renovascular hypertension].
    Helber A, Hummerich W, Bönner G, Meurer KA, Moritz G.
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():208-9. PubMed ID: 613575
    [No Abstract] [Full Text] [Related]

  • 6. Outpatient experience with saralasin.
    Streeten DH, Anderson GH.
    Kidney Int Suppl; 1979 Mar; (9):S44-52. PubMed ID: 289863
    [No Abstract] [Full Text] [Related]

  • 7. Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
    Yamamoto J.
    Jpn Circ J; 1977 Jun; 41(6):665-75. PubMed ID: 886656
    [No Abstract] [Full Text] [Related]

  • 8. Effect of the angiotensin II blocker 1-Sar-8-Ala-angiotensin II on renal artery clip hypertension in the rat.
    Macdonald GJ, Boyd GW, Peart WS.
    Circ Res; 1975 Nov; 37(5):640-6. PubMed ID: 1192561
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II blockade: evidence for baroreceptor-mediated renin release and the role of sodium balance.
    Baer L, Parra-Carrillo JZ, Radichevich I.
    Kidney Int Suppl; 1979 Mar; (9):S60-7. PubMed ID: 289865
    [No Abstract] [Full Text] [Related]

  • 10. Greene LL, Ferreira SH: Potential screening test for detection of overactivity of renin-angiotensin system.
    Krieger EM, Salgado HC, Assan CJ.
    Lancet; 1971 Feb 06; 1(7693):269-71. PubMed ID: 4100019
    [No Abstract] [Full Text] [Related]

  • 11. Effect of administration of Sar1-Ala8-angiotensin II during the development and maintenance of renal hypertension in the rat.
    Fernandes M, Fiorentini R, Onesti G, Bellini G, Gould AB, Hessan H, Kim KE, Swartz C.
    Clin Sci Mol Med; 1978 Jun 06; 54(6):633-7. PubMed ID: 657733
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin as a renal, adrenal, and cardiovascular hormone: responses to saralasin in normal man and in essential and secondary hypertension.
    Hollenberg NK, Williams GH.
    Kidney Int Suppl; 1979 Mar 06; (9):S29-35. PubMed ID: 384070
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.